Notch1 regulates hepatic thrombopoietin production

dc.contributor.authorSun, Yueyueen
dc.contributor.authorTong, Huanen
dc.contributor.authorChu, Xiangen
dc.contributor.authorLi, Yingyingen
dc.contributor.authorZhang, Jieen
dc.contributor.authorDing, Yangyangen
dc.contributor.authorZhang, Sixuanen
dc.contributor.authorGui, Xiangen
dc.contributor.authorChen, Chongen
dc.contributor.authorXu, Mengdien
dc.contributor.authorLi, Zhenyuen
dc.contributor.authorGardiner, Elizabeth E.en
dc.contributor.authorAndrews, Robert K.en
dc.contributor.authorZeng, Lingyuen
dc.contributor.authorXu, Kailinen
dc.contributor.authorQiao, Jianlinen
dc.date.accessioned2025-12-17T21:41:11Z
dc.date.available2025-12-17T21:41:11Z
dc.date.issued2024-04-11en
dc.description.abstractNotch signaling regulates cell-fate decisions in several developmental processes and cell functions. However, the role of Notch in hepatic thrombopoietin (TPO) production remains unclear. We noted thrombocytopenia in mice with hepatic Notch1 deficiency and so investigated TPO production and other features of platelets in these mice. We found that the liver ultrastructure and hepatocyte function were comparable between control and Notch1-deficient mice. However, the Notch1-deficient mice had significantly lower plasma TPO and hepatic TPO messenger RNA levels, concomitant with lower numbers of platelets and impaired megakaryocyte differentiation and maturation, which were rescued by addition of exogenous TPO. Additionally, JAK2/STAT3 phosphorylation was significantly inhibited in Notch1-deficient hepatocytes, consistent with the RNA-sequencing analysis. JAK2/STAT3 phosphorylation and TPO production was also impaired in cultured Notch1-deficient hepatocytes after treatment with desialylated platelets. Consistently, hepatocyte-specific Notch1 deletion inhibited JAK2/STAT3 phosphorylation and hepatic TPO production induced by administration of desialylated platelets in vivo. Interestingly, Notch1 deficiency downregulated the expression of HES5 but not HES1. Moreover, desialylated platelets promoted the binding of HES5 to JAK2/STAT3, leading to JAK2/STAT3 phosphorylation and pathway activation in hepatocytes. Hepatocyte Ashwell-Morell receptor (AMR), a heterodimer of asialoglycoprotein receptor 1 [ASGR1] and ASGR2, physically associates with Notch1, and inhibition of AMR impaired Notch1 signaling activation and hepatic TPO production. Furthermore, blockage of Delta-like 4 on desialylated platelets inhibited hepatocyte Notch1 activation and HES5 expression, JAK2/STAT3 phosphorylation, and subsequent TPO production. In conclusion, our study identifies a novel regulatory role of Notch1 in hepatic TPO production, indicating that it might be a target for modulating TPO level.en
dc.description.sponsorshipThis work was supported by National Natural Science Foundation of China (grants 82322005, 82261138554, 82170130, 81970124, and 81400082), National Key Research and Development Program of China (grant 2023YFC2507800), the Natural Science Foundation of Jiangsu Province (grant BK20140219), funding for the Distinguished Professorship Program of Jiangsu Province, the Shuangchuang Project of Jiangsu Province, the 333 projects of Jiangsu Province (grant BRA2017542), the Natural Science Foundation of the Jiangsu Higher Education Institutions of China (grant 18KJA320010), Jiangsu Province's Graduate Scientific Research Innovation Program (grants KYCX23-2930, KYCX22-2896, and KYCX21-2691), Youth Science and Technology Innovation Team of Xuzhou Medical University, and the National Health and Medical Research Council of Australia. Contribution: Y.S. H.T. and X.C. performed research, analyzed data, and wrote the manuscript; Y.L. J.Z. Y.D. S.Z. X.G. C.C. M.X. and Z.L. performed research and analyzed data; E.E.G. and R.K.A. provided the intellectual input; L.Z. K.X. and J.Q. conceived and designed the study and wrote the manuscript; and all authors read and revised the manuscript. This work was supported by National Natural Science Foundation of China (grant numbers 82322005 , 82261138554 , 82170130 , 81970124 , and 81400082 ), the Natural Science Foundation of Jiangsu Province (grant number BK20140219 ), the funding for the Distinguished Professorship Program of Jiangsu Province , the Shuangchuang Project of Jiangsu Province , the 333 projects of Jiangsu Province ( BRA2017542 ), the Natural Science Foundation of the Jiangsu Higher Education Institutions of China ( 18KJA320010 ), Jiangsu Province's Graduate Scientific Research Innovation Program ( KYCX23-2930 , KYCX22-2896 , and KYCX21-2691 ), Youth Science and Technology Innovation Team of Xuzhou Medical University , and the National Health and Medical Research Council of Australia.en
dc.description.statusPeer-revieweden
dc.format.extent13en
dc.identifier.issn0006-4971en
dc.identifier.otherPubMed:38603632en
dc.identifier.otherWOS:001261949900001en
dc.identifier.otherORCID:/0000-0001-9453-9688/work/188017768en
dc.identifier.scopus85192549697en
dc.identifier.urihttps://hdl.handle.net/1885/733796449
dc.language.isoenen
dc.rights© 2024 The Author(s)en
dc.sourceBlooden
dc.subjectBindingen
dc.subjectSignaling pathwayen
dc.subjectLiveren
dc.subjectStat3en
dc.subjectMiceen
dc.subjectClearanceen
dc.subjectModifieren
dc.titleNotch1 regulates hepatic thrombopoietin productionen
dc.typeJournal articleen
dspace.entity.typePublicationen
local.bibliographicCitation.lastpage2790en
local.bibliographicCitation.startpage2778en
local.contributor.affiliationSun, Yueyue; Xuzhou Medical Universityen
local.contributor.affiliationTong, Huan; Xuzhou Medical Universityen
local.contributor.affiliationChu, Xiang; Xuzhou Medical Universityen
local.contributor.affiliationLi, Yingying; Xuzhou Medical Universityen
local.contributor.affiliationZhang, Jie; Xuzhou Medical Universityen
local.contributor.affiliationDing, Yangyang; Xuzhou Medical Universityen
local.contributor.affiliationZhang, Sixuan; Xuzhou Medical Universityen
local.contributor.affiliationGui, Xiang; Xuzhou Medical Universityen
local.contributor.affiliationChen, Chong; Xuzhou Medical Universityen
local.contributor.affiliationXu, Mengdi; Xuzhou Medical Universityen
local.contributor.affiliationLi, Zhenyu; Xuzhou Medical Universityen
local.contributor.affiliationGardiner, Elizabeth E.; Genome Sciences, Genome Sciences and Cancer Division, John Curtin School of Medical Research, ANU College of Science and Medicine, The Australian National Universityen
local.contributor.affiliationAndrews, Robert K.; John Curtin School of Medical Research, ANU College of Science and Medicine, The Australian National Universityen
local.contributor.affiliationZeng, Lingyu; Xuzhou Medical Universityen
local.contributor.affiliationXu, Kailin; Xuzhou Medical Universityen
local.contributor.affiliationQiao, Jianlin; Xuzhou Medical Universityen
local.identifier.citationvolume143en
local.identifier.doi10.1182/blood.2023023559en
local.identifier.purecb7faf1c-09cc-4d62-b353-64735af720been
local.identifier.urlhttps://www.scopus.com/pages/publications/85192549697en
local.type.statusPublisheden

Downloads